PillMedulla Ossis Suis, Spleen (Bovine), Thymus (Ovine), Carcinosin, Cytomegalovirus Nosode, Influenzinum (2022-2023), Streptococcus Viridans, Toxoplasma Gondii, Epstein-Bar Virus Nosode
Brands: Fatigue Formula · Sus Scrofa Bone Marrow + Bos Taurus Spleen + Lamb + Human Breast Tumor Cell + Human Herpesvirus 5 + Influenza A Virus A/Victoria/2570/2019 Ivr-215 (H1n1) Antigen (Uv, Formaldehyde Inactivated) + Influenza A Virus A/Darwin/9/2021 Ivr-228 (H3n2) Antigen (Uv, Formaldehyde Inactivated) + Influenza B Virus B/Austria/1359417/2021 Bvr-26 Antigen (Uv, Formaldehyde Inactivated) + Influenza B Virus B/Phuket/3073/2013 Antigen (Uv, Formaldehyde Inactivated) + Streptococcus Viridans Group + Toxoplasma Gondii + Human Herpesvirus 4
0 active makers
soon
soon
soon
soon
Medicaid dispensing volume
No Medicaid utilization on record for this drug concept yet. Quarterly volume (CMS State Drug Utilization Data) loads with the utilization ETL.
Who makes it0 active · 1 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Nutritional Specialties, Inc. | unknown | 1 | EXITED 2028 |
Regulatory & supply events
No recalls, shortages, or registration changes on record for this drug concept.